Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Shock Waves in Knee Arthritis

NCT: NCT06833372 · RECRUITING

NCT IDNCT06833372
StatusRECRUITING
Start Date2025-10-01
Completion2027-09-01

Brief Summary

Pathological arthritis is a degenerative disease affecting the joints, characterized by pain, limitation of movement up to ankylosis and disability. Treatment is aimed at reducing pain and slowing the loss of functionality of the district. Among conservative treatments, pharmacological options (NSAIDs, cortisone, contrasupplements, hyaluronic acid) and non-pharmacological options (therapeutic exercise, physical therapy, orthosis, etc.) are indicated. In cases not responding to conservative treatments, surgical treatment will be necessary with prosthetic replacement of the joint district.

Frequently Asked Questions

What is Shock Waves in Knee Arthritis?

Shock Waves in Knee Arthritis is a clinical trial registered under NCT06833372. Current status: RECRUITING.

What is the status of NCT06833372?

The current status of NCT06833372 (Shock Waves in Knee Arthritis) is: RECRUITING.

When did Shock Waves in Knee Arthritis start?

Shock Waves in Knee Arthritis started on 2025-10-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.